Publications by authors named "Mark Strand"

Claim this Profile
C
Commending Public Health in a Time of Uncertainty.
Mark A Strand, Juliana Antwi, Valentina Asiedu

J Public Health Manag Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creation of the CAP center: Advancing pharmacy practice through implementation science integration.
Elizabeth Skoy, Heidi Eukel, Brody Maack, Lisa Nagel, Mark Strand

J Am Pharm Assoc (2003)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of pharmacy in promoting public health: Pharmacy and public health in 2050.
Mark A Strand

J Am Pharm Assoc (2003)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A faculty development series on race and ethnicity in pharmacy education.
Mark A Strand, Allison Hursman, Brody Maack, Natasha Petry, Rose Yang

Curr Pharm Teach Learn· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supernatural Beliefs-Based Intervention to Improve Type-2 Diabetes Self-Management: A Pilot Randomized Controlled Trial from China.
Stephen W Pan, Amy Wachholtz, Mark Strand, Wanqi Wang, Shiqiang Wu

J Relig Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a North Dakota opioid misuse and overdose prevention program in West Virginia.
Elizabeth Skoy, Rebecca Linger, Heidi Eukel, Susan Murphy, Oliver Frenzel, Mark Strand

J Am Pharm Assoc (2003)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the opioid and naloxone education (ONE) program: Program evaluation using the RE-AIM model four years later.
Mark A Strand, Oliver Frenzel

Res Social Adm Pharm· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A call to develop opioid risk assessment programs for implementation in the pharmacy setting.
Alyssa Hodges, Anna Skarphol, Mark A Strand

J Am Pharm Assoc (2003)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Removal of Rheumatoid Nodule That Presented as a Thyroglossal Duct Cyst: A Case Report.
Jacob M Tupa, Jace R Otremba, Mark D Strand

Ear Nose Throat J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing the Risk of COVID-19 Using Model Based Predictors: The Case of North Dakota.
Savita K Sidhu, Adam Hohman, Mark A Strand, Omobosinuola Shyllon, Rick Jansen

Disaster Med Public Health Prep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative Analysis of a Roundtable Exercise "Reflecting on the COVID-19 Experience of Public Health Professionals".
Mark A Strand, Savita Sidhu, Adam Hohman, Rick Jansen, Stephen McDonough

J Public Health Manag Pract· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nurse delivered medication safety screening program for home care visits.
Heidi N Eukel, Jayme Steig, Alyssa Hodges, Brianna O'Gary, Mark A Strand

Public Health Nurs· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Longitudinal Comparison of Pharmacy Documentation Platforms Using the Technology Acceptance Model: Experiences With Opioid Risk Screening.
Oliver C Frenzel, Mark Strand, Allison Welsh, Heidi Eukel, Elizabeth Skoy

J Pharm Technol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid risk stratification in the community pharmacy: The utility of the Opioid Risk Tool.
Mark A Strand, Heidi N Eukel, Oliver Frenzel, Elizabeth Skoy, Jayme Steig

Res Social Adm Pharm· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Community Pharmacist-Delivered Care for Patients With Psychiatric Disorders Filling an Opioid Prescription.
Amy Werremeyer, Oliver Frenzel, Mark A Strand, Heidi Eukel, Elizabeth Skoy

Psychiatr Serv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental Overdose.
Elizabeth Skoy, Oliver Frenzel, Heidi Eukel, Emily Lothspeich, Jayme Steig, Mark Strand

Prev Chronic Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid risk screening: Program evaluation from the community pharmacists' perspective.
Oliver Frenzel, Heidi Eukel, Emily Lothspeich, Elizabeth Skoy, Jayme Steig, Mark Strand

J Am Pharm Assoc (2003)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Association of Face Covering Mandates on COVID-19 Severity by State.
Mark A Strand, Omobosinuola Shyllon, Adam Hohman, Rick J Jansen, Savita Sidhu

J Prim Care Community Health· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal evaluation of pharmacists' social distance preference and attitudes toward patients with opioid misuse following an educational training program.
Amy Werremeyer, Mark A Strand, Heidi Eukel, Elizabeth Skoy, Jayme Steig

Subst Abus· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose.
Elizabeth Skoy, Amy Werremeyer, Jayme Steig, Heidi Eukel, Oliver Frenzel, Mark Strand

Subst Abus· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacists' stigma toward patients engaged in opioid misuse: When "social distance" does not mean disease prevention.
Amy Werremeyer, Sydney Mosher, Heidi Eukel, Elizabeth Skoy, Jayme Steig, Mark A Strand

Subst Abus· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid Misuse and Overdose: Changes in Pharmacist Practices and Outcomes.
Heidi Eukel, Jayme Steig, Oliver Frenzel, Elizabeth Skoy, Amy Werremeyer, Mark Strand

J Contin Educ Health Prof· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening at a Federally Qualified Health Center in the Midwest for Hepatitis C Among People Who Inject Drugs, 2019-2020.
Melissa Perkins, Amber Slevin, Mark A Strand, Daniel Freisner

Prev Chronic Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining Attitudes and Beliefs that Inhibit Pharmacist Implementation of a Statewide Opioid Harm Reduction Program.
Oliver C Frenzel, Heidi Eukel, Elizabeth Skoy, Amy Werremeyer, Jayme Steig, Mark Strand

Innov Pharm· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy Contributions to Improved Population Health: Expanding the Public Health Roundtable.
Mark A Strand, Natalie A DiPietro Mager, Lori Hall, Sarah Levin Martin, Daniel F Sarpong

Prev Chronic Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis